Valuation: Precipio, Inc.

Market Cap 54.43M 46.62M 43.62M 39.93M 74.94M 5.21B 75.93M 515M 201M 2.62B 204M 200M 8.65B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 55.43M 47.48M 44.43M 40.67M 76.32M 5.3B 77.33M 525M 205M 2.66B 208M 204M 8.81B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.37%
Yield 2024 *
-
Yield 2025 -
1 day+3.47%
1 week+29.57%
Current month+40.65%
1 month+28.48%
3 months+23.98%
6 months+20.07%
Current year+32.51%
1 week 22.96
Extreme 22.96
30.45
1 month 19.22
Extreme 19.22
30.45
Current year 19.22
Extreme 19.22
33.63
1 year 14.04
Extreme 14.04
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap.
7/15/26 A Free

Director

520 0.0291%
7/15/26 A Free

Director

416 0.0233%
7/15/26 A Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
+3.47%+29.57%+110.00%+299.61% 54.43M
-0.84%+3.92%+28.04%-29.04% 17.87B
-3.05%-7.40%-38.72%+93.72% 1.64B
-0.74%+3.08%-42.56%-80.75% 1.01B
+1.26%+0.44%-21.55%+28.94% 997M
+0.11%+0.11%+63.23%-6.33% 780M
-2.29%-1.45%-36.91%-46.86% 689M
-1.91%-12.67%-44.02%-44.74% 566M
+3.23%+2.36%-39.55%-34.64% 457M
+3.19%+6.69%+77.41%+50.00% 441M
Average +0.24%+2.22%+5.54%+22.99% 2.45B
Weighted average by Cap. -0.78%+2.29%+16.09%-18.71%

Financials

2024 2025
Net sales 18.53M 15.87M 14.85M 13.6M 25.52M 1.77B 25.85M 175M 68.43M 891M 69.59M 68.07M 2.95B 24.05M 20.6M 19.28M 17.64M 33.11M 2.3B 33.55M 228M 88.81M 1.16B 90.3M 88.34M 3.82B
Net income -4.29M -3.67M -3.44M -3.15M -5.91M -410M -5.98M -40.62M -15.84M -206M -16.11M -15.76M -682M -363K -311K -291K -266K -500K -34.73M -506K -3.44M -1.34M -17.45M -1.36M -1.33M -57.71M
Net Debt -136K -116K -109K -99.78K -187K -13.01M -190K -1.29M -502K -6.54M -511K -500K -21.62M 1M 858K 803K 735K 1.38M 95.87M 1.4M 9.49M 3.7M 48.16M 3.76M 3.68M 159M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
21/08/26 $30.45 +3.47% 69,645
20/08/26 $29.43 +5.67% 366,640
19/08/26 $27.85 +12.80% 92,809
18/08/26 $24.69 +3.31% 331,444
17/08/26 $23.90 +1.70% 49,749
  1. Stock Market
  2. Stocks
  3. PRPO Stock